Affinity NMR
Because binding ligands are directly detected and identified, the diffusion-based NMR method and NOE pumping approach promise to greatly simplify deconvolution in drug screening. An additional advantage of these techniques is that low-affinity ligands, which might be missed by high-throughput screen...
Gespeichert in:
Veröffentlicht in: | Analytical chemistry (Washington) 1999-10, Vol.71 (19), p.669A-675A |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 675A |
---|---|
container_issue | 19 |
container_start_page | 669A |
container_title | Analytical chemistry (Washington) |
container_volume | 71 |
creator | AIDI CHEN SHAPIRO, M. J |
description | Because binding ligands are directly detected and identified, the diffusion-based NMR method and NOE pumping approach promise to greatly simplify deconvolution in drug screening. An additional advantage of these techniques is that low-affinity ligands, which might be missed by high-throughput screening, can be detected and could serve as synthetic precursors for higher affinity ligands. The biggest challenge to NMR methodology lies in its sensitivity. Compared with other techniques, such as MS (25), NMR methods for screening mixtures are limited by their relative insensitivity. Because of issues such as solubility, stability, and mass limitation, it is not in general judicious to simply increase the concentration of the mixture. Improvements in hardware and software are necessary to extend the applicability of the affinity NMR method to the screening of larger and more complex mixtures. A boost in sensitivity and screening capacity of NMR technique is possible by the implementation of microcoil (26) and flow probe techniques. An upsurge in the capabilities of mixture analysis could be achieved with a combination of independent and complementary techniques (e.g., HPLC, MS) (27). As a unique, nondestructive, and versatile tool, NMR will continue on its fast track of development in the support of drug discovery. |
doi_str_mv | 10.1021/ac9907179 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_70827731</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70827731</sourcerecordid><originalsourceid>FETCH-LOGICAL-p263t-2c6b8dd4f88f8dc179fc61442636722efdcd96e2f39dbff766f15e082a1e7af3</originalsourceid><addsrcrecordid>eNpdz01LAzEQBuAgiq2tB_-AiIi31ZlkO0mOpfgFVUF6X9IkA1t2t3XTPfTfu-KK4GkO78PMO0JcINwhSLx33lrQqO2RGONMQkbGyGMxBgCVSQ0wEmcpbQAQAelUjBBmqFHRWEznzGVT7g9Xb68fU3HCrkrxfJgTsXp8WC2es-X708tivsx2ktQ-k57WJoScjWETfH-XPWGe9yFpKSMHHyxFycqGNbMmYpxFMNJh1I7VRNz-rN21288upn1Rl8nHqnJN3Hap0D3VWmEPr__BzbZrm75aIVGbnEh-o8sBdes6hmLXlrVrD8Xvjz24GYBL3lXcusaX6c9ZTcpq9QVppluP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217846621</pqid></control><display><type>article</type><title>Affinity NMR</title><source>MEDLINE</source><source>ACS Publications</source><creator>AIDI CHEN ; SHAPIRO, M. J</creator><creatorcontrib>AIDI CHEN ; SHAPIRO, M. J</creatorcontrib><description>Because binding ligands are directly detected and identified, the diffusion-based NMR method and NOE pumping approach promise to greatly simplify deconvolution in drug screening. An additional advantage of these techniques is that low-affinity ligands, which might be missed by high-throughput screening, can be detected and could serve as synthetic precursors for higher affinity ligands. The biggest challenge to NMR methodology lies in its sensitivity. Compared with other techniques, such as MS (25), NMR methods for screening mixtures are limited by their relative insensitivity. Because of issues such as solubility, stability, and mass limitation, it is not in general judicious to simply increase the concentration of the mixture. Improvements in hardware and software are necessary to extend the applicability of the affinity NMR method to the screening of larger and more complex mixtures. A boost in sensitivity and screening capacity of NMR technique is possible by the implementation of microcoil (26) and flow probe techniques. An upsurge in the capabilities of mixture analysis could be achieved with a combination of independent and complementary techniques (e.g., HPLC, MS) (27). As a unique, nondestructive, and versatile tool, NMR will continue on its fast track of development in the support of drug discovery.</description><identifier>ISSN: 0003-2700</identifier><identifier>EISSN: 1520-6882</identifier><identifier>DOI: 10.1021/ac9907179</identifier><identifier>PMID: 10517136</identifier><identifier>CODEN: ANCHAM</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Biological and medical sciences ; Chemistry ; Drug Evaluation, Preclinical - methods ; General pharmacology ; Image Processing, Computer-Assisted ; Ligands ; Magnetic Resonance Spectroscopy - methods ; Matrix Metalloproteinase 3 - analysis ; Matrix Metalloproteinase 3 - metabolism ; Medical sciences ; NMR ; Nuclear magnetic resonance ; Pharmacology. Drug treatments ; Physicochemical properties. Structure-activity relationships ; Receptors, Drug - metabolism ; Salicylic Acid - metabolism ; Serum Albumin - analysis ; Serum Albumin - metabolism</subject><ispartof>Analytical chemistry (Washington), 1999-10, Vol.71 (19), p.669A-675A</ispartof><rights>1999 INIST-CNRS</rights><rights>Copyright American Chemical Society Oct 1, 1999</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1976397$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10517136$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>AIDI CHEN</creatorcontrib><creatorcontrib>SHAPIRO, M. J</creatorcontrib><title>Affinity NMR</title><title>Analytical chemistry (Washington)</title><addtitle>Anal Chem</addtitle><description>Because binding ligands are directly detected and identified, the diffusion-based NMR method and NOE pumping approach promise to greatly simplify deconvolution in drug screening. An additional advantage of these techniques is that low-affinity ligands, which might be missed by high-throughput screening, can be detected and could serve as synthetic precursors for higher affinity ligands. The biggest challenge to NMR methodology lies in its sensitivity. Compared with other techniques, such as MS (25), NMR methods for screening mixtures are limited by their relative insensitivity. Because of issues such as solubility, stability, and mass limitation, it is not in general judicious to simply increase the concentration of the mixture. Improvements in hardware and software are necessary to extend the applicability of the affinity NMR method to the screening of larger and more complex mixtures. A boost in sensitivity and screening capacity of NMR technique is possible by the implementation of microcoil (26) and flow probe techniques. An upsurge in the capabilities of mixture analysis could be achieved with a combination of independent and complementary techniques (e.g., HPLC, MS) (27). As a unique, nondestructive, and versatile tool, NMR will continue on its fast track of development in the support of drug discovery.</description><subject>Biological and medical sciences</subject><subject>Chemistry</subject><subject>Drug Evaluation, Preclinical - methods</subject><subject>General pharmacology</subject><subject>Image Processing, Computer-Assisted</subject><subject>Ligands</subject><subject>Magnetic Resonance Spectroscopy - methods</subject><subject>Matrix Metalloproteinase 3 - analysis</subject><subject>Matrix Metalloproteinase 3 - metabolism</subject><subject>Medical sciences</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Pharmacology. Drug treatments</subject><subject>Physicochemical properties. Structure-activity relationships</subject><subject>Receptors, Drug - metabolism</subject><subject>Salicylic Acid - metabolism</subject><subject>Serum Albumin - analysis</subject><subject>Serum Albumin - metabolism</subject><issn>0003-2700</issn><issn>1520-6882</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdz01LAzEQBuAgiq2tB_-AiIi31ZlkO0mOpfgFVUF6X9IkA1t2t3XTPfTfu-KK4GkO78PMO0JcINwhSLx33lrQqO2RGONMQkbGyGMxBgCVSQ0wEmcpbQAQAelUjBBmqFHRWEznzGVT7g9Xb68fU3HCrkrxfJgTsXp8WC2es-X708tivsx2ktQ-k57WJoScjWETfH-XPWGe9yFpKSMHHyxFycqGNbMmYpxFMNJh1I7VRNz-rN21288upn1Rl8nHqnJN3Hap0D3VWmEPr__BzbZrm75aIVGbnEh-o8sBdes6hmLXlrVrD8Xvjz24GYBL3lXcusaX6c9ZTcpq9QVppluP</recordid><startdate>19991001</startdate><enddate>19991001</enddate><creator>AIDI CHEN</creator><creator>SHAPIRO, M. J</creator><general>American Chemical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QF</scope><scope>7QO</scope><scope>7QQ</scope><scope>7SC</scope><scope>7SE</scope><scope>7SP</scope><scope>7SR</scope><scope>7TA</scope><scope>7TB</scope><scope>7TM</scope><scope>7U5</scope><scope>7U7</scope><scope>7U9</scope><scope>8BQ</scope><scope>8FD</scope><scope>C1K</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>H94</scope><scope>JG9</scope><scope>JQ2</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19991001</creationdate><title>Affinity NMR</title><author>AIDI CHEN ; SHAPIRO, M. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p263t-2c6b8dd4f88f8dc179fc61442636722efdcd96e2f39dbff766f15e082a1e7af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Biological and medical sciences</topic><topic>Chemistry</topic><topic>Drug Evaluation, Preclinical - methods</topic><topic>General pharmacology</topic><topic>Image Processing, Computer-Assisted</topic><topic>Ligands</topic><topic>Magnetic Resonance Spectroscopy - methods</topic><topic>Matrix Metalloproteinase 3 - analysis</topic><topic>Matrix Metalloproteinase 3 - metabolism</topic><topic>Medical sciences</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Pharmacology. Drug treatments</topic><topic>Physicochemical properties. Structure-activity relationships</topic><topic>Receptors, Drug - metabolism</topic><topic>Salicylic Acid - metabolism</topic><topic>Serum Albumin - analysis</topic><topic>Serum Albumin - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AIDI CHEN</creatorcontrib><creatorcontrib>SHAPIRO, M. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Aluminium Industry Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Electronics & Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Materials Business File</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ANTE: Abstracts in New Technology & Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Analytical chemistry (Washington)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AIDI CHEN</au><au>SHAPIRO, M. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Affinity NMR</atitle><jtitle>Analytical chemistry (Washington)</jtitle><addtitle>Anal Chem</addtitle><date>1999-10-01</date><risdate>1999</risdate><volume>71</volume><issue>19</issue><spage>669A</spage><epage>675A</epage><pages>669A-675A</pages><issn>0003-2700</issn><eissn>1520-6882</eissn><coden>ANCHAM</coden><abstract>Because binding ligands are directly detected and identified, the diffusion-based NMR method and NOE pumping approach promise to greatly simplify deconvolution in drug screening. An additional advantage of these techniques is that low-affinity ligands, which might be missed by high-throughput screening, can be detected and could serve as synthetic precursors for higher affinity ligands. The biggest challenge to NMR methodology lies in its sensitivity. Compared with other techniques, such as MS (25), NMR methods for screening mixtures are limited by their relative insensitivity. Because of issues such as solubility, stability, and mass limitation, it is not in general judicious to simply increase the concentration of the mixture. Improvements in hardware and software are necessary to extend the applicability of the affinity NMR method to the screening of larger and more complex mixtures. A boost in sensitivity and screening capacity of NMR technique is possible by the implementation of microcoil (26) and flow probe techniques. An upsurge in the capabilities of mixture analysis could be achieved with a combination of independent and complementary techniques (e.g., HPLC, MS) (27). As a unique, nondestructive, and versatile tool, NMR will continue on its fast track of development in the support of drug discovery.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>10517136</pmid><doi>10.1021/ac9907179</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-2700 |
ispartof | Analytical chemistry (Washington), 1999-10, Vol.71 (19), p.669A-675A |
issn | 0003-2700 1520-6882 |
language | eng |
recordid | cdi_proquest_miscellaneous_70827731 |
source | MEDLINE; ACS Publications |
subjects | Biological and medical sciences Chemistry Drug Evaluation, Preclinical - methods General pharmacology Image Processing, Computer-Assisted Ligands Magnetic Resonance Spectroscopy - methods Matrix Metalloproteinase 3 - analysis Matrix Metalloproteinase 3 - metabolism Medical sciences NMR Nuclear magnetic resonance Pharmacology. Drug treatments Physicochemical properties. Structure-activity relationships Receptors, Drug - metabolism Salicylic Acid - metabolism Serum Albumin - analysis Serum Albumin - metabolism |
title | Affinity NMR |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T15%3A44%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Affinity%20NMR&rft.jtitle=Analytical%20chemistry%20(Washington)&rft.au=AIDI%20CHEN&rft.date=1999-10-01&rft.volume=71&rft.issue=19&rft.spage=669A&rft.epage=675A&rft.pages=669A-675A&rft.issn=0003-2700&rft.eissn=1520-6882&rft.coden=ANCHAM&rft_id=info:doi/10.1021/ac9907179&rft_dat=%3Cproquest_pubme%3E70827731%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=217846621&rft_id=info:pmid/10517136&rfr_iscdi=true |